These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9400599)

  • 1. Mutations affecting the sensitivity of the influenza virus neuraminidase to 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid.
    Goto H; Bethell RC; Kawaoka Y
    Virology; 1997 Nov; 238(2):265-72. PubMed ID: 9400599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en.
    Blick TJ; Tiong T; Sahasrabudhe A; Varghese JN; Colman PM; Hart GJ; Bethell RC; McKimm-Breschkin JL
    Virology; 1995 Dec; 214(2):475-84. PubMed ID: 8553549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en.
    Staschke KA; Colacino JM; Baxter AJ; Air GM; Bansal A; Hornback WJ; Munroe JE; Laver WG
    Virology; 1995 Dec; 214(2):642-6. PubMed ID: 8553569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid.
    Gubareva LV; Penn CR; Webster RG
    Virology; 1995 Oct; 212(2):323-30. PubMed ID: 7571401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2,3-didehydro-2,4-dideoxy-4-guanidino-N-acetyl-D-neuraminic acid (4-guanidino-Neu5Ac2en) is a slow-binding inhibitor of sialidase from both influenza A virus and influenza B virus.
    Hart GJ; Bethell RC
    Biochem Mol Biol Int; 1995 Jul; 36(4):695-703. PubMed ID: 8528132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro.
    Zürcher T; Yates PJ; Daly J; Sahasrabudhe A; Walters M; Dash L; Tisdale M; McKimm-Breschkin JL
    J Antimicrob Chemother; 2006 Oct; 58(4):723-32. PubMed ID: 16891631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of influenza A and B viruses for resistance to 4-guanidino-Neu5Ac2en in cell culture.
    Colacino JM; Laver WG; Air GM
    J Infect Dis; 1997 Aug; 176 Suppl 1():S66-8. PubMed ID: 9240698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en.
    Gubareva LV; Robinson MJ; Bethell RC; Webster RG
    J Virol; 1997 May; 71(5):3385-90. PubMed ID: 9094607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the neuraminidase inhibitor 4-guanidino-Neu5Ac2en leads to instability of the enzyme.
    McKimm-Breschkin JL; McDonald M; Blick TJ; Colman PM
    Virology; 1996 Nov; 225(1):240-2. PubMed ID: 8918554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro.
    Woods JM; Bethell RC; Coates JA; Healy N; Hiscox SA; Pearson BA; Ryan DM; Ticehurst J; Tilling J; Walcott SM
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1473-9. PubMed ID: 8363379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single sequence change destabilizes the influenza virus neuraminidase tetramer.
    Colacino JM; Chirgadze NY; Garman E; Murti KG; Loncharich RJ; Baxter AJ; Staschke KA; Laver WG
    Virology; 1997 Sep; 236(1):66-75. PubMed ID: 9299618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en.
    Blick TJ; Sahasrabudhe A; McDonald M; Owens IJ; Morley PJ; Fenton RJ; McKimm-Breschkin JL
    Virology; 1998 Jun; 246(1):95-103. PubMed ID: 9656997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en.
    McKimm-Breschkin JL; Blick TJ; Sahasrabudhe A; Tiong T; Marshall D; Hart GJ; Bethell RC; Penn CR
    Antimicrob Agents Chemother; 1996 Jan; 40(1):40-6. PubMed ID: 8787876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en.
    Gubareva LV; Bethell R; Hart GJ; Murti KG; Penn CR; Webster RG
    J Virol; 1996 Mar; 70(3):1818-27. PubMed ID: 8627706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors.
    McKimm-Breschkin JL; Sahasrabudhe A; Blick TJ; McDonald M; Colman PM; Hart GJ; Bethell RC; Varghese JN
    J Virol; 1998 Mar; 72(3):2456-62. PubMed ID: 9499107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir.
    Buxton RC; Edwards B; Juo RR; Voyta JC; Tisdale M; Bethell RC
    Anal Biochem; 2000 May; 280(2):291-300. PubMed ID: 10790313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication.
    Suzuki T; Takahashi T; Guo CT; Hidari KI; Miyamoto D; Goto H; Kawaoka Y; Suzuki Y
    J Virol; 2005 Sep; 79(18):11705-15. PubMed ID: 16140748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro generation and characterisation of an influenza B variant with reduced sensitivity to neuraminidase inhibitors.
    Cheam AL; Barr IG; Hampson AW; Mosse J; Hurt AC
    Antiviral Res; 2004 Sep; 63(3):177-81. PubMed ID: 15451185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides.
    Smith PW; Sollis SL; Howes PD; Cherry PC; Starkey ID; Cobley KN; Weston H; Scicinski J; Merritt A; Whittington A; Wyatt P; Taylor N; Green D; Bethell R; Madar S; Fenton RJ; Morley PJ; Pateman T; Beresford A
    J Med Chem; 1998 Mar; 41(6):787-97. PubMed ID: 9526555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slow-binding inhibition of sialidase from influenza virus.
    Pegg MS; von Itzstein M
    Biochem Mol Biol Int; 1994 Apr; 32(5):851-8. PubMed ID: 8069234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.